
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
The Regional Access Manager will be responsible to ensure and optimize access of the BeOne´s pipeline at a regional level, building strategic relationships and engaging with regional payers/payer organizations (and their influencers), and public affairs stakeholders.
This individual is a field based employee with extensive market access experience who is responsible of the development of projects, budgetary control and to present value evidences tools to payers and those with budgetary responsibility at regional level.
The Regional Access Manager´s activity is designed to shape a favourable environment for our products and services through effective and targeted communication with payers at a Regional and Local level as dictated by the local country business.
Computer Skills: Standard Computer Skills required
Travel: Approximately 75% of time
Salary Range Spain: 99,400.00 EUR - 124,200.00 EUR
Global Competencies
When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.
We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible.
To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.